Showing results (21-30 of 102) with videos related to
Sort By:
Pageof 11
Cell Cycle (Georgetown, Tex.)|May 10, 2017
The CDK4/6 inhibitor palbociclib synergizes with irinotecan to promote colorectal cancer cell death under hypoxiaJun Zhang, Lanlan Zhou, Shuai Zhao, et al.Journal of Experimental & Clinical Cancer Research : CR|January 24, 2018
Anti-tumor effects of ONC201 in combination with VEGF-inhibitors significantly impacts colorectal cancer growth and survival in vivo through complementary non-overlapping mechanismsJessica Wagner, C Leah Kline, Lanlan Zhou, et al.Oncology Reports|July 4, 2012
Extracellular protease imaging for cell mass tracking of xenografted human malignant pleural mesotheliomaLanlan Zhou, Wafik El-Deiry, Wenge Wang, et al.Frontiers in Pharmacology|November 5, 2021
Integrating Molecular Biomarker Inputs Into Development and Use of Clinical Cancer TherapeuticsAnna D Louie, Kelsey Huntington, Lindsey Carlsen, et al.Frontiers in Psychology|August 22, 2022
Attention impairment in patients with cervical dystonia: An attention network test studyKun Xia, Yongsheng Han, Lanlan Zhou, et al.F1000Research|September 5, 2017
Circulating tumor cells: silent predictors of metastasisLanLan Zhou, David T Dicker, Elizabeth Matthew, et al.Cancer Biology & Therapy|July 26, 2011
Prediction of proapoptotic anticancer therapeutic response in vivo based on cell death visualization and TRAIL death ligand-receptor interactionLanLan Zhou, Wenge Wang, David T Dicker, et al.Healthcare (Basel, Switzerland)|October 25, 2024
Development and Validation of the Communities Geriatric Mild Cognitive Impairment Risk Calculator (CGMCI-Risk)Jiangwei Chen, Qing Fang, Kehua Yang, et al.Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|July 5, 2023
Vitexin inhibits pain and itch behavior via modulating TRPV4 activity in miceZhiqiang Qin, Lan Xiang, Siyu Zheng, et al.Frontiers in Pharmacology|September 17, 2021
Absence of Biomarker-Driven Treatment Options in Small Cell Lung Cancer, and Selected Preclinical Candidates for Next Generation Combination TherapiesNicholas R Liguori, Young Lee, William Borges, et al.Pageof 11